Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Donatella Boschi

Showing results (1-10 of 51) with videos related to

Pageof 6
Sort By:
Antiviral Research|February 12, 2025
DHODH inhibitors: What will it take to get them into the clinic as antivirals?Anna Luganini, Donatella Boschi, Marco L Lolli, et al.
European Journal of Medicinal Chemistry|September 27, 2019
Dihydroorotate dehydrogenase inhibitors in anti-infective drug researchDonatella Boschi, Agnese Chiara Pippione, Stefano Sainas, et al.
Rapid Communications in Mass Spectrometry : RCM|May 15, 2018
Fragmentation pathways arising from protonation at different sites in aminoalkyl-substituted 3-hydroxy-1,2,5-oxadiazoles (3-hydroxyfurazans)J Stuart Grossert, Donatella Boschi, Marco L Lolli, et al.
European Journal of Medicinal Chemistry|April 15, 2023
Phenothiazines as anti-cancer agents: SAR overview and synthetic strategiesArun Kumar, Chiara Vigato, Donatella Boschi, et al.
European Journal of Mass Spectrometry (Chichester, England)|November 17, 2023
Intramolecular interactions and the neutral loss of ammonia from collisionally activated, protonated ω-aminoalkyl-3-hydroxyfurazansJ Stuart Grossert, Donatella Boschi, Marco L Lolli, et al.
Bioorganic & Medicinal Chemistry Letters|May 3, 2011
Synthesis and in vitro antimicrobial activities of new (cyano-NNO-azoxy)pyrazole derivativesDonatella Boschi, Stefano Guglielmo, Stefania Aiello, et al.
Viruses|October 27, 2022
The Novel <i>h</i>DHODH Inhibitor MEDS433 Prevents Influenza Virus Replication by Blocking Pyrimidine BiosynthesisGiulia Sibille, Anna Luganini, Stefano Sainas, et al.
Journal of Mass Spectrometry : JMS|December 5, 2015
Heterocyclic ring cleavage upon collision-induced dissociation of deprotonated 3-hydroxy-1,2,5-oxadiazoles (3-hydroxyfurazans)J Stuart Grossert, Agnese C Pippione, Donatella Boschi, et al.
Recent Patents on Anti-Cancer Drug Discovery|November 10, 2017
Use of human Dihydroorotate Dehydrogenase (hDHODH) Inhibitors in Autoimmune Diseases and New Perspectives in Cancer TherapyMarco L Lolli, Stefano Sainas, Agnese C Pippione, et al.
Chemico-Biological Interactions|August 18, 2009
Novel nitro-oxy derivatives of celecoxib for the regulation of colon cancer cell growthFrancesca Bozzo, Andrea Bassignana, Loretta Lazzarato, et al.
Pageof 6

Showing results (1-10 of 51) with videos related to

Sort By:
Pageof 6
Antiviral Research|February 12, 2025
DHODH inhibitors: What will it take to get them into the clinic as antivirals?Anna Luganini, Donatella Boschi, Marco L Lolli, et al.
European Journal of Medicinal Chemistry|September 27, 2019
Dihydroorotate dehydrogenase inhibitors in anti-infective drug researchDonatella Boschi, Agnese Chiara Pippione, Stefano Sainas, et al.
Rapid Communications in Mass Spectrometry : RCM|May 15, 2018
Fragmentation pathways arising from protonation at different sites in aminoalkyl-substituted 3-hydroxy-1,2,5-oxadiazoles (3-hydroxyfurazans)J Stuart Grossert, Donatella Boschi, Marco L Lolli, et al.
European Journal of Medicinal Chemistry|April 15, 2023
Phenothiazines as anti-cancer agents: SAR overview and synthetic strategiesArun Kumar, Chiara Vigato, Donatella Boschi, et al.
European Journal of Mass Spectrometry (Chichester, England)|November 17, 2023
Intramolecular interactions and the neutral loss of ammonia from collisionally activated, protonated ω-aminoalkyl-3-hydroxyfurazansJ Stuart Grossert, Donatella Boschi, Marco L Lolli, et al.
Bioorganic & Medicinal Chemistry Letters|May 3, 2011
Synthesis and in vitro antimicrobial activities of new (cyano-NNO-azoxy)pyrazole derivativesDonatella Boschi, Stefano Guglielmo, Stefania Aiello, et al.
Viruses|October 27, 2022
The Novel <i>h</i>DHODH Inhibitor MEDS433 Prevents Influenza Virus Replication by Blocking Pyrimidine BiosynthesisGiulia Sibille, Anna Luganini, Stefano Sainas, et al.
Journal of Mass Spectrometry : JMS|December 5, 2015
Heterocyclic ring cleavage upon collision-induced dissociation of deprotonated 3-hydroxy-1,2,5-oxadiazoles (3-hydroxyfurazans)J Stuart Grossert, Agnese C Pippione, Donatella Boschi, et al.
Recent Patents on Anti-Cancer Drug Discovery|November 10, 2017
Use of human Dihydroorotate Dehydrogenase (hDHODH) Inhibitors in Autoimmune Diseases and New Perspectives in Cancer TherapyMarco L Lolli, Stefano Sainas, Agnese C Pippione, et al.
Chemico-Biological Interactions|August 18, 2009
Novel nitro-oxy derivatives of celecoxib for the regulation of colon cancer cell growthFrancesca Bozzo, Andrea Bassignana, Loretta Lazzarato, et al.
Pageof 6